Perfect B | 8200 NW 41st St, Suite 100, Doral, FL 33166 (786) 502-2260 Not sure which peptide protocol fits your recovery goal
The JPML found that the GLP-1 NAION lawsuits shared common questions of fact, including allegations that Plaintiffs use of certain GLP-1 RA drugs caused them to suffer from non-arteritic anterior ischemic optic neuropathy (NAION)
If the powder does not dissolve immediately, let the vial sit at room temperature for a few minutes and try gentle swirling again
In Phase 1 and Phase 2 human studies (20222023) subjects showed weight reductions of up to 24 % of baseline over 48 weeks
You may be a candidate if: You have documented excess visceral fat with imaging or waist circumference criteria You have features of metabolic syndrome elevated triglycerides, insulin resistance, impaired fasting glucose You have evidence of GH-axis insufficiency or age-related GH decline (low IGF-1) You have not achieved adequate visceral fat reduction through lifestyle modification alone You are being treated for HIV-associated lipodystrophy (the FDA-approved indication) You are not pregnant and do not have active malignancy both are absolute contraindications Lab workup typically includes: Fasting IGF-1 level Fasting glucose and insulin (HOMA-IR for insulin resistance) Full lipid panel Hemoglobin A1c Liver function tests Baseline CT or MRI for VAT quantification (in research settings) Meto's Comprehensive Metabolic Panel covers the core biomarkers fasting glucose, fasting insulin, lipid panel, liver markers, and inflammation markers giving your provider the baseline data needed to evaluate your candidacy accurately
